Anders Friberg

4PUBLICATIONS
13CO-AUTHORS
Proteins and peptidesMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 19, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A2 Group V (hPLA2-G5) for the Treatment of Inflammatory Pain.

|Sep 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.

Jeffrey Mowat, Rafael Carretero, Gabriele Leder

|Dec 21, 2022
Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".

Douglas L Orsi, Elisabeth Pook, Nico Bräuer

|Oct 21, 2022
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069.

Douglas L Orsi, Elisabeth Pook, Nico Bräuer

Pageof 1

Frequent Collaborators

3 joint publications

Nico Bräuer

2 joint publications

Knut Eis

2 joint publications

Jonathan T Goldstein

1 joint publications

Douglas L Orsi